Vectura Group Share Price (VEC)

144.00 -0.50 (-0.35%) delayed: 11:27AM BST
Bid price 143.75 Open price 144.75
Ask price 144.25 Prev close 144.50
High price 145.00 Spread 0.35%
Low price 143.25 Volume 88,673

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index n/a

Vectura Group Key Numbers

Latest Share Price (p) 144.00 Net Gearing (%) -0.13
Market Capitalisation (£m) 578.92 Gross Gearing (%) 26.40
Shares in issue (m) 401.66 Debt Ratio 22.10
P/E Ratio -205.90 Debt-to-Equity Ratio 0.79
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.36
Dividend Yield (%) 0.00 Price to book value 2.55
Dividend cover (x) 0.00 ROCE -0.03
Earning per share (p) -0.70 EPS Growth (%) 61.11
52 week high / low 171.50 / 94.25 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
08/07/2014 BUY Dr Christopher Blackwell CEO 1,212
08/07/2014 BUY Dr Trevor Phillips ED 1,212
08/07/2014 BUY Paul Oliver FD 1,212
02/07/2014 EXR John Brown NED 238,989
02/07/2014 SEXR John Brown NED 159,100

More Vectura Group Director Deals >>

Vectura Group Company News

07:50 19/08/2014

Vectura says business, pipeline progressing in line

Vectura Group said following the acquisition of Activaero GmbH in March 2014, the integration of the business is progressing well and Vectura's product pipeline is progressing in line with the Board's expectations. Its comment was part of an IMS for the period April 1 to Aug. 19. It said its...

07:00 19/08/2014

Notice of AGM

/* */ RNS Number : 4111P Vectura Group plc 19 August 2014    Vectura Group plc (the "Company") Notice of AGM   Chippenham, UK, 19 August 2014 : Vectura Group plc (LSE: VEC) today gives notice of the following:...

07:04 19/08/2014

FLASH: Vectura says business, pipeline progressing in line

Story provided by

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

07 hours ago


Powered by IST's

Register now for FREE Vectura Group share price discussions